Health-related quality of life and late morbidity in concurrent chemoradiation and radiotherapy alone in patients with locally advanced cervical carcinoma

Journal of Gynecologic Oncology

Volumn 22, Issue 3, 2011, Pages 152-160

  Berveling, Maaike J ^a   Langendijk, Johannes A ^a   Beukema, Jannet C ^a   Mourits, Marian J E ^a   Reyners, Anna K L ^a   Pras, Elisabeth ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Cervical carcinoma; Concurrent radiochemotherapy; Late treatment related morbidity; Radiotherapy

Indexed keywords

CARBOPLATIN; FLUOROURACIL;

ARTICLE; BLADDER DISEASE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHEMORADIOTHERAPY; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; MAJOR CLINICAL STUDY; MORBIDITY; MULTIPLE CYCLE TREATMENT; QUALITY OF LIFE; RADIATION SICKNESS; RETROSPECTIVE STUDY; SMALL INTESTINE DISEASE; URINARY FREQUENCY; URINE INCONTINENCE; UTERINE CERVIX CARCINOMA;

EID: 80053011690     PISSN: 20050380     EISSN: 20050399     Source Type: Journal    
DOI: 10.3802/jgo.2011.22.3.152     Document Type: Article

References (33)

1. Maduro JH, Pras E, Willemse PH, de Vries EG. Acute and long-term toxicity following radiotherapy alone or in combination with chemotherapy for locally advanced cervical cancer. Cancer Treat Rev 2003;29:471-88.
2. Kirwan JM, Symonds P, Green JA, Tierney J, Collingwood M, Williams CJ. A systematic review of acute and late toxicity of concomitant chemoradiation for cervical cancer. Radiother Oncol 2003;68:217-26.
3. Denton AS, Bond SJ, Matthews S, Bentzen SM, Maher EJ; UK Link Gynaecology-Oncology Group. National audit of the management and outcome of carcinoma of the cervix treated with radiotherapy in 1993. Clin Oncol (R Coll Radiol) 2000;12:347-53.
4. Lajer H, Thranov IR, Skovgaard LT, Engelholm SA. Late urologic morbidity in 177 consecutive patients after radiotherapy for cervical carcinoma: a longitudinal study. Int J Radiat Oncol Biol Phys 2002;54:1356-61.
5. National Cancer Institutes. Guidelines gynaecologic tumours: cervical carcinoma [Internet]. Bethesda, MD: National Cancer Instututes; 2004 [cited 2011 Jun 20]. Available from: http://www.cancer.gov.
6. Thomas GM. Improved treatment for cervical cancer: concurrent chemotherapy and radiotherapy. N Engl J Med 1999;340:1198-200.
7. Ozsaran Z, Kamer S, Yalman D, Akagunduz O, Aras A. Treatment results and prognostic factors for cervical cancer patients treated by radiochemotherapy with weekly cisplatin. Eur J Gynaecol Oncol 2007;28:196-200.
8. King M, McConkey C, Latief TN, Hartley A, Fernando I. Improved survival after concurrent weekly cisplatin and radiotherapy for cervical carcinoma with assessment of acute and late side-effects. Clin Oncol (R Coll Radiol) 2006;18:38-45.
9. Bentzen SM, Dorr W, Anscher MS, Denham JW, Hauer-Jensen M, Marks LB, et al. Normal tissue effects: reporting and analysis. Semin Radiat Oncol 2003;13:189-202.
10. van der Zee J, Gonzalez Gonzalez D, van Rhoon GC, van Dijk JD, van Putten WL, Hart AA. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial: Dutch Deep Hyperthermia Group. Lancet 2000;355:1119-25.
11. Chassagne D, Sismondi P, Horiot JC, Sinistrero G, Bey P, Zola P, et al. A glossary for reporting complications of treatment in gynecological cancers. Radiother Oncol 1993;26:195-202.
12. Eifel PJ, Winter K, Morris M, Levenback C, Grigsby PW, Cooper J, et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol 2004;22:872-80.
13. Green JA, Kirwan JM, Tierney JF, Symonds P, Fresco L, Collingwood M, et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and metaanalysis. Lancet 2001;358:781-6.
14. Rose PG. Chemoradiotherapy for cervical cancer. Eur J Cancer 2002;38:270-8.
15. Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol 2008;26:5802-12.
16. Lukka H, Hirte H, Fyles A, Thomas G, Elit L, Johnston M, et al. Concurrent cisplatin-based chemotherapy plus radiotherapy for cervical cancer: a meta-analysis. Clin Oncol (R Coll Radiol) 2002;14:203-12.
17. Tan LT, Russell S, Burgess L. Acute toxicity of chemoradiotherapy for cervical cancer: the Addenbrooke's experience. Clin Oncol (R Coll Radiol) 2004;16:255-60.
18. National Cancer Institute. Common Terminology Criteria for Adverse Events v. 3.0. [Internet]. Bethesda, MD: National Cancer Instututes; 2003 [cited 2011 Jun 20]. Available from: http://ctep.cancer.gov.
19. European Organization for Research and Treatment of Cancer. EORTC QLQ-C30 [Internet]. Brussel: EORTC; 2005 [cited cited 2011 Jun 20]. Available from: http://www.eortc.be.
20. Anacak Y, Yalman D, Ozsaran Z, Haydarog lu A. Late radiation effects to the rectum and bladder in gynecologic cancer patients: the comparison of LENT/ SOMA and RTOG/EORTC late-effects scoring systems. Int J Radiat Oncol Biol Phys 2001;50:1107-12.
21. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;31:1341-6.
22. Overgaard J, Bartelink H. About tolerance and quality: an important notice to all radiation oncologists. Radiother Oncol 1995;35:1-3.
23. Routledge JA, Burns MP, Swindell R, Khoo VS, West CM, Davidson SE. Evaluation of the LENT-SOMA scales for the prospective assessment of treatment morbidity in cervical carcinoma. Int J Radiat Oncol Biol Phys 2003;56:502-10.
24. Trotti A, Byhardt R, Stetz J, Gwede C, Corn B, Fu K, et al. Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy. Int J Radiat Oncol Biol Phys 2000;47:13-47.
25. Trotti A, Colevas AD, Setser A, Rusch V, Jaques D, Budach V, et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 2003;13:176-81.
26. Pras E, Willemse PH, Boonstra H, Hollema H, Heesters MA, Szabo BG, et al. Concurrent chemo-and radiotherapy in patients with locally advanced carcinoma of the cervix. Ann Oncol 1996;7:511-6.
27. Willemse PH, de Vries EG, Pras E, Maduro JH. Treatment of cervical cancer. Lancet 2002;359:357-8.
28. Nijhuis ER, van der Zee AG, in't Hout BA, Boomgaard JJ, de Hullu JA, Pras E, et al. Gynecologic examination and cervical biopsies after (chemo) radiation for cervical cancer to identify patients eligible for salvage surgery. Int J Radiat Oncol Biol Phys 2006;66:699-705.
29. Kok AL, Voorhorst FJ, Halff-Butter CM, Janssens J, Kenemans P. The prevalence of urinary incontinence in elderly women. Ned Tijdschr Geneeskd 1991;135:98-101.
30. Coia LR, Myerson RJ, Tepper JE. Late effects of radiation therapy on the gastrointestinal tract. Int J Radiat Oncol Biol Phys 1995;31:1213-36.
31. Bye A, Trope C, Loge JH, Hjermstad M, Kaasa S. Healthrelated quality of life and occurrence of intestinal side effects after pelvic radiotherapy: evaluation of longterm effects of diagnosis and treatment. Acta Oncol 2000;39:173-80.
32. Beriwal S, Gan GN, Heron DE, Selvaraj RN, Kim H, Lalonde R, et al. Early clinical outcome with concurrent chemotherapy and extended-field, intensity-modulated radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys 2007;68:166-71.
33. Wachter-Gerstner N, Wachter S, Reinstadler E, Fellner C, Knocke TH, Wambersie A, et al. Bladder and rectum dose defined from MRI based treatment planning for cervix cancer brachytherapy: comparison of dosevolume histograms for organ contours and organ wall, comparison with ICRU rectum and bladder reference point. Radiother Oncol 2003;68:269-76.